Thomas M. Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer: Who Truly Benefits? AJR Am J Roentgenol 2025 Aug 13. doi: 10.2214/AJR.25.33698.
PMID: 40801500